4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-24-007138
EVP R&D, Chief Medical Officer gave up 3,414 shares (to pay taxes)
- EVP R&D, Chief Medical Officer acquired 7,689 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hopkinson Craig C. · EVP R&D, Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-23 | Exercise or conversion : show line 1 in the form | +7,689 | 113,123 | D | ||
| 2024-02-23 | Shares withheld for taxes : show line 2 in the form | −3,414 | $29.57 | $100,952 | 109,709 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-23 | Exercise or conversion : show line 3 in the form Restricted Stock Unit Award | −7,689 | 23,068 | D |
| 2024-02-26 | Grant or award : show line 4 in the form Employee Stock Option (Right to Buy) | +111,186 | 111,186 | D |
| 2024-02-26 | Grant or award : show line 5 in the form Restricted Stock Unit Award | +27,464 | 27,464 | D |
Loading xslF345X05/form4.xml…